Latest Headlines

  1. Andelyn Biosciences And ENCell Co., Ltd Announce Strategic Partnership To Expand Global Reach Of Gene Therapy Manufacturing 4/21/2026

    Andelyn Biosciences, ("Andelyn") a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization ("CDMO"), and ENCell Co., Ltd. ("ENCell"), a Korea-based advanced biopharmaceutical CDMO, announced today the signing of a Collaboration Agreement to establish a strategic manufacturing bridge between the United States and Asia-Pacific (APAC) regions to accelerate the global delivery of life-changing gene therapies.

  2. One Brand Uniting Critical Fluid Management Components 4/17/2026

    CPC Biotech to make its public debut at INTERPHEX 2026, April 21–23, Javits Center, New York City.

  3. CDMO Kincell Bio Announces Expansion Of North Carolina Manufacturing Hub 4/15/2026

    Kincell Bio, a leading contract development and manufacturing organization (CDMO) supporting autologous and allogeneic cell therapy programs, today announced a significant strategic investment to expand and strengthen its Research Triangle Park (RTP), North Carolina, facility. The expansion reinforces Kincell Bio’s commitment to supporting clients as they advance from late-stage clinical CMC development through commercialization and post-approval life cycle management.

  4. AST And Marchesini Group Debut Partnership Benefit With Expanded Drug Product Manufacturing Portfolio At INTERPHEX 2026 4/14/2026
  5. Andelyn Biosciences Partners With Evolyra Therapeutics For The Clinical Manufacturing Of Gene Therapies For The Treatment Of Limb-Girdle Muscular Dystrophies 4/14/2026

     Andelyn Biosciences, a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), announced today a partnership with Evolyra Therapeutics to manufacture clinical-grade AAV gene therapies for treating types 2C and 2D Limb-Girdle Muscular Dystrophies (LGMDs).

  6. Ensorcell Launches Versaweld™ Precision Tube Welding Platform At INTERPHEX 2026 4/10/2026
  7. Bracco Investing In Geneva Facility To Scale Cell Therapy Manufacturing 4/2/2026

    Bracco Imaging, a global pharmaceutical company that develops, manufactures, and markets innovative healthcare solutions, announced an upgrade of its manufacturing site in Geneva to support clinical-grade GMP manufacturing of its cell therapy-enabling microbubble technology, building on its previously announced investments in the site since 2019. Commercial access to the GMP-grade cell selection and activation product will be ready by the middle of 2027.

  8. Lonza Launches Media Development Lab In Singapore For Cell Culture Media Optimization 3/26/2026

    Lonza, one of the world’s largest contract development and manufacturing organizations (CDMOs), today announced the launch of its Media Development Lab at its Singapore site.

  9. Avance Clinical Appoints Liahna Toy To Lead Global Early Phase Center Of Excellence 3/23/2026

    Avance Clinical, a global full-service CRO headquartered in Australia dedicated to servicing biotech, announces the appointment of Liahna Toy as Senior Vice President & Head of Early Phase Center of Excellence, reinforcing the company’s strategic focus on accelerating high-quality early-phase trials for emerging biotech sponsors.

  10. Avance Clinical Strengthens Global Oncology Offering With Acquisition Of U.S-Based LumaBridge 3/23/2026

    Avance Clinical, a global contract research organization focused on accelerating clinical development for biotech sponsors, today announced the acquisition of LumaBridge, a specialized U.S.-based clinical CRO with deep expertise in oncology trials.